Literature DB >> 3262122

Evidence for glomerular actions of epidermal growth factor in the rat.

R C Harris1, R L Hoover, H R Jacobson, K F Badr.   

Abstract

Epidermal growth factor (EGF), an endogenous mitogenic peptide, has recently been shown to be a potent vasoconstrictor of vascular smooth muscle. In view of its potential role in proliferative and inflammatory renal glomerular diseases, we examined the effects of EGF both on cultured rat mesangial cells and on in vivo glomerular hemodynamics. Mesangial cells possess specific, saturable EGF receptors of differing affinities, with Kd's of 0.1 and 1.7 nM, respectively. EGF produced a rapid increase in intracellular pH of 0.12 +/- 0.01 pH U, which was sodium dependent and amiloride inhibitable. The addition of EGF to mesangial cells cultured on either glass or dimethylpolysiloxane substratum induced reproducible cell contraction. Intrarenal EGF infusion did not affect systemic blood pressure or hematocrit but reversibly decreased GFR and renal blood flow from 4.19 +/- 0.33 to 3.33 +/- 0.26 and from 1.17 +/- 0.09 to 0.69 +/- 0.07 ml/min, respectively. Glomerular micropuncture confirmed decreases in single nephron plasma flow and in single nephron GFR (from 142 +/- 9 to 98 +/- 8 and from 51.6 +/- 11.7 to 28.5 +/- 3.5 nl/min, respectively) which were due to significant increases in both pre- and postglomerular arteriolar resistances (from 1.97 +/- 0.31 to 2.65 +/- 0.36 and from 1.19 +/- 0.11 to 2.00 +/- 0.15 10(10) dyn.s.cm-5 respectively) and to a significant decrease in the ultrafiltration coefficient, Kf, which fell from 0.100 +/- 0.019 to 0.031 +/- 0.007 nl/(s.mmHg). These studies demonstrate that mesangial cells possess specific receptors for EGF, and exposure of these cells to physiologic concentrations of EGF results in an in vitro functional response characterized by activation of Na+/H+ exchange and by resultant intracellular alkalinization, as well as by cell contraction. EGF administration in vivo significantly reduces the glomerular capillary ultrafiltration coefficient, Kf, which, in combination with EGF-induced constriction of both preglomerular and postglomerular arterioles, results in acute major reductions in the rates of glomerular filtration and perfusion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262122      PMCID: PMC303617          DOI: 10.1172/JCI113659

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

Review 2.  Mechanisms of regulation of the Na+/H+ exchanger.

Authors:  S Grinstein; A Rothstein
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

3.  Resolution of high and low affinity epidermal growth factor receptors. Inhibition of high affinity component by low temperature, cycloheximide, and phorbol esters.

Authors:  A C King; P Cuatrecasas
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

4.  Properties of the receptor for epidermal growth factor.

Authors:  G Carpenter
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

5.  Angiotensin II-stimulated Na+/H+ exchange in cultured vascular smooth muscle cells. Evidence for protein kinase C-dependent and -independent pathways.

Authors:  B C Berk; M S Aronow; T A Brock; E Cragoe; M A Gimbrone; R W Alexander
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

6.  Vascular actions of epidermal growth factor-urogastrone: possible relationship to prostaglandin production.

Authors:  I Muramatsu; M D Hollenberg; K Lederis
Journal:  Can J Physiol Pharmacol       Date:  1985-08       Impact factor: 2.273

7.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues.

Authors:  L B Rall; J Scott; G I Bell; R J Crawford; J D Penschow; H D Niall; J P Coghlan
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

8.  Cellular transformation by coordinated action of three peptide growth factors from human platelets.

Authors:  R K Assoian; G R Grotendorst; D M Miller; M B Sporn
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

Review 9.  Allosteric regulation of the epidermal growth factor receptor kinase.

Authors:  J Schlessinger
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Intracellular pH transients in squid giant axons caused by CO2, NH3, and metabolic inhibitors.

Authors:  W F Boron; P De Weer
Journal:  J Gen Physiol       Date:  1976-01       Impact factor: 4.086

View more
  26 in total

Review 1.  Polypeptide growth factors and the kidney: a developmental perspective.

Authors:  E D Avner
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

Review 2.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

3.  Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.

Authors:  Zhilian Li; Yan Li; Jessica M Overstreet; Sungjin Chung; Aolei Niu; Xiaofeng Fan; Suwan Wang; Yinqiu Wang; Ming-Zhi Zhang; Raymond C Harris
Journal:  Diabetes       Date:  2018-06-29       Impact factor: 9.461

4.  Modulation of Na+,K(+)-ATPase activity by a tyrosine phosphorylation process in rat proximal convoluted tubule.

Authors:  E Féraille; M L Carranza; M Rousselot; H Favre
Journal:  J Physiol       Date:  1997-01-01       Impact factor: 5.182

5.  The Role of the EGF Receptor in Sex Differences in Kidney Injury.

Authors:  Ming-Zhi Zhang; Kensuke Sasaki; Yan Li; Zhilian Li; Yu Pan; Guan-Nan Jin; Yinqiu Wang; Aolei Niu; Suwan Wang; Xiaofeng Fan; Jian Chun Chen; Corina Borza; Haichun Yang; Ambra Pozzi; Agnes B Fogo; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2019-07-10       Impact factor: 10.121

6.  Localization of epidermal growth factor (EGF) binding sites on antiluminal plasma membrane of rat kidney: autoradiographic study using nonfiltering perfused rat kidney.

Authors:  D C Kim; Y Sugiyama; Y Kanai; N Ohnuma; M Hanano
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

7.  Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat.

Authors:  L Vinter-Jensen; M Smerup; P E Jørgensen; C O Juhl; T Orntoft; S S Poulsen; E Nexø
Journal:  Urol Res       Date:  1996

8.  Expression of epidermal growth factor in the rat kidney. An immunocytochemical and in situ hybridization study.

Authors:  E C Salido; J Lakshmanan; D A Fisher; L J Shapiro; L Barajas
Journal:  Histochemistry       Date:  1991

Review 9.  The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Authors:  Fenghua Zeng; Amar B Singh; Raymond C Harris
Journal:  Exp Cell Res       Date:  2008-08-19       Impact factor: 3.905

10.  Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs.

Authors:  C O Juhl; L Vinter-Jensen; L S Jensen; E Nexø; J C Djurhuus; E Z Dajani
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.